RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Palo Alto, CA · Sacramento, CA · +49 more sites
2 recruiting psoriasis studies with a site in Palo Alto, CA.
Sponsor: National Cancer Institute (NCI)
Palo Alto, CA · Sacramento, CA · +49 more sites
Sponsor: Duke University
Los Angeles, CA · Palo Alto, CA · +72 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.